NCT02686060View on ClinicalTrials.gov

In-line Filtration to Reduce Systemic Inflammatory Response Syndrome in Babies Born Very prEtErm

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 5, 2017

Study Completion Date

November 30, 2017

Conditions
Babies Born Very Preterm
Interventions
DEVICE

0.2 micron positively charged PALL Corporation filters and 1.2 micro IV in-line filters used for lipid administration

Trial Locations (1)

75019

Hopital Robert Debre, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02686060 - In-line Filtration to Reduce Systemic Inflammatory Response Syndrome in Babies Born Very prEtErm | Biotech Hunter | Biotech Hunter